Skip to main content
Caplight Logo









Luna Diabetes

Luna Diabetes

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.lunadiabetes.com/

Last Round

Series A

Aug 18, 2025

Est. Valuation

$45.5M

Total Funding Raised

$23.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Luna Diabetes is a medical device company that develops an automated insulin delivery patch pump system designed for nighttime glucose control for insulin pen users.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

insulin patch pumpautomated insulin deliveryAIDclosed-loop dosingcontinuous glucose monitorCGMartificial pancreasdiabetes managementtime-in-rangeTIRmultiple daily injectionsMDImedical devicedigital healthwearable medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luna Diabetes Comparables

Compare Luna Diabetes with similar companies based on industry and business-model similarity.

Luna Diabetes comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaSens AG
77%
Insulet Corporation
67%
Beta Bionics
67%

Luna Diabetes Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 18, 2025

Key People

Founding team and executive leadership

John Sjolund

CEO & Co-Founder

Founding Team

Luna Diabetes Investors

Notable investors and investment history

Luna Diabetes investors
InvestorRounds
2468 VenturesSeries A
Serpentine VenturesSeries A
Vensana CapitalSeries A
Winklevoss CapitalSeries A
Interlock CapitalSeries A
Credit Suisse Group AGSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 19% QoQ, from 16 to 19 employees.

  • Jul 25, 2026

    Monthly visitors increased 47% MoM, reaching 2.7K.

Luna Diabetes Filings

Explore SEC and related filing metadata, where available.

Luna Diabetes filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Luna Diabetes's valuation, stock price, and market status.

Is Luna Diabetes a public or private company?

Luna Diabetes is a private company.

What is the current stock price of Luna Diabetes?

Luna Diabetes is a private company with no public stock price. No recent secondary market data is available.

How much is Luna Diabetes worth (valuation)?

Valuation information for Luna Diabetes is not publicly available.

Can I buy Luna Diabetes stock?

Luna Diabetes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Luna Diabetes's last funding round?

Luna Diabetes's most recent funding round was Series A on August 18, 2025.

Who are the main investors in Luna Diabetes?

Key investors in Luna Diabetes include Vensana Capital.

Will Luna Diabetes IPO soon?

No public IPO plans have been announced for Luna Diabetes.

How can I track Luna Diabetes secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luna Diabetes's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range11
Year Founded2020
Last FundingAug 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?